Cytyc, a provider of surgical and diagnostic products targeting women's health and cancer diagnostics, and Xoft, a point-of-care radiation therapy company, said they have settled an intellectual property dispute involving balloon-based brachytherapy technologies developed by both companies for the treatment of breast cancer patients.

Although specific financial terms were not disclosed, the agreement calls for the Fremont, Calif.-based Xoft to make royalty payments to the Marlborough, Mass.-based Cytyc.

The agreement allows Xoft freedom of operation in the ongoing sales of its Axxent electronic brachytherapy system. The companies reported that they have also agreed to discuss potential collaboration in the development of technologies in several areas, including women’s health.